The Flu Shot Doesn’t Really Keep Older Adults Out of the Hospital: A 2020 Study Raises Questions on False Claims
Originally published: 2025-02-18
Every fall, the push for flu shots ramps up—especially for older adults, who are told it’s a critical shield against the flu’s worst outcomes. The messaging is clear: get vaccinated, stay healthy, avoid the hospital. But a 2020 study titled "Influenza Vaccination and Hospitalization Outcomes Among Older Adults in the United States" throws a curveball into this narrative. Published in the International Journal of Environmental Research and Public Health, this research dives into Medicare data to ask a big question: does the flu shot actually reduce hospitalizations and deaths among seniors as much as we think? The findings might surprise you—and they’ve certainly sparked some debate
The Study: A Clever Design and a Massive Scope
The researchers, led by a team digging into public health data, zeroed in on a natural experiment baked into the U.S. healthcare system. At age 65, Americans become eligible for Medicare, and with that milestone comes a sharp uptick in flu vaccination rates—thanks to coverage, doctor nudges, and public health campaigns. The study used a method called regression discontinuity design (RDD), which is a fancy way of saying they compared people just under 65 to those just over 65 to see if that vaccination boost made a difference in health outcomes.
Their dataset was jaw-dropping: 170 million "episodes" of care from Medicare beneficiaries between 2009 and 2017. That’s not 170 million flu shots in one year, mind you, but a massive sample of healthcare interactions across nearly a decade, capturing vaccination status and outcomes like hospitalizations and mortality tied to flu and pneumonia. The idea was simple: if the flu shot works as advertised, you’d expect a noticeable drop in these bad outcomes right at the age-65 mark, where vaccination rates jump from about 50% to 65% or more.
The Findings: A Head-Scratcher
Here’s where things get interesting—and a little unsettling. The study found that, yes, vaccination rates spiked significantly at 65. No surprise there; the system works as intended to get more shots in arms. But when they looked at hospitalizations and deaths linked to influenza and pneumonia, the needle didn’t move. There was no clear reduction in these outcomes corresponding to that vaccination increase. In statistical terms, the effect was negligible—close to zero. Even when they zoomed in on specific causes like respiratory illnesses or accounted for seasonal flu patterns, the result held: more shots didn’t translate to fewer hospital beds or funerals.
This isn’t a small claim. For years, observational studies have suggested flu vaccines cut hospitalization risk by 30–50% in older adults, depending on the season and strain match. The CDC touts numbers like these to promote vaccination. So, what gives? Why does this study see no impact where others do?
Interpreting the Results: What’s Going On?
The authors offer a few possibilities. One is that the flu vaccine’s real-world effectiveness in older adults might be lower than we’ve assumed. As we age, our immune systems weaken—a phenomenon called immunosenescence—making it harder to mount a strong response to vaccines. The standard flu shot might not pack enough punch for seniors, even if it works better in younger, healthier folks. Another angle is that flu-related hospitalizations might be driven more by secondary complications (like bacterial pneumonia) or misdiagnosed cases, diluting the vaccine’s measurable impact.
Then there’s the method itself. RDD is powerful because it mimics a randomized trial by exploiting a sharp cutoff (age 65), reducing bias from factors like income or health habits that often skew vaccine studies. But it’s not perfect. It assumes the only big change at 65 is vaccination, which might not fully hold—Medicare access could shift other healthcare behaviors too. Plus, the study spans multiple flu seasons with varying vaccine effectiveness, which could mask benefits in “good” years.
Critics argue the findings clash with decades of evidence. Randomized trials and meta-analyses consistently show flu vaccines reduce illness severity, even if they don’t always stop infection. But the authors counter that many prior studies rely on weaker designs—observational data where vaccinated people might already be healthier or better cared for, inflating perceived benefits. This study’s strength is its attempt to cut through that noise.
The Bigger Picture: What Does It Mean?
So, should older adults ditch the flu shot? This study says it didn’t noticeably cut hospitalizations or deaths at the population level in this specific analysis.
The findings poke holes in the blanket assurance that flu shots are a silver bullet for hospital avoidance. They’ve fueled online chatter—think X posts from Alex Berenson, who’ve seized on it to question vaccine dogma. Public health officials, meanwhile, might double down on the broader evidence base, arguing one study doesn’t overturn the consensus.
Maybe it’s time to rethink vaccine strategies for older adults. Or perhaps we need better diagnostics to pinpoint flu’s true burden, separating it from the soup of winter illnesses. Either way, the study’s a reminder that science isn’t static; it thrives on tough questions.
